insights_auto
Why is KNSA up 6,25%?
Dive Deeperchevron_right
KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
93,86 USD
arrow_upward
+6,25%(+5,52) 1D
95,00 USD
arrow_upward
+1,21% (+1,14)bedtimeAfter hours
Closed: 6-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KNSA...
Open
88,92 USD
High
94,48 USD
Low
88,41 USD
Mkt. cap
7,37 млд
Avg. vol.
830,89 миң
Volume
636,35 миң
P/E ratio
71,64
52-wk high
98,48 USD
52-wk low
37,02 USD
EPS
1,31 USD
Beta
0,07
Shares outstanding
48,84 млн
No. of employees
366
Open
88,92 USD
High
94,48 USD
Low
88,41 USD
Mkt. cap
7,37 млд
Avg. vol.
830,89 миң
Volume
636,35 миң
P/E ratio
71,64
52-wk high
98,48 USD
52-wk low
37,02 USD
EPS
1,31 USD
Beta
0,07
Shares outstanding
48,84 млн
No. of employees
366
News stories
From web sources and news partners
Quantisnow
·
12 саат мурун
KNSA CEO Patel sold 151,300 shares for $14.3M at an average $94.71
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
HeadquartersЛондон, Ингленд, Улуу Британия
SectorHealth Care
Industry-
Websitekiniksa.com